ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.
Clinical trial NCT03792568 · UNKNOWN
Trial details
- NCT number
- NCT03792568
- Sponsor
- Shanghai Changzheng Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2019-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.